View Scopus Profile

Massimo Cristofanilli

Professor, Medicine, Hematology Oncology Division

Phone+1 312 472 0573
Emailmassimo.cristofanilli@northwestern.edu

Source: Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

10 Finished
19 Active

19 results

Filter

Active

Circulating Endothelial Cells as Biomarkers of Cardiovascular Events in Patients with COVID-19
Akhter, N. & Cristofanilli, M.
Menarini Silicon Biosystems, Inc.
1/7/21 → 1/7/24
Project: Research project
Unraveling New Cytokine-Mediated Mechanisms to Enhance Response to CDK4/6 inhibition in ER+/HER2-Metastatic Breast Cancer
Cristofanilli, M. & Vasilopoulos, A.
MetaVivor Research and Support, Inc.
10/5/20 → 10/4/23
Project: Research project
Glycoprotein sialylation of CTC clusters in breast cancer metastasis
Cristofanilli, M., Jia, Y. & Liu, H.
U.S. Army Medical Research and Materiel Command
9/1/20 → 8/31/23
Project: Research project
Targeting CysLTR1 in triple negative breast cancer
Cristofanilli, M. & Zhang, B.
U.S. Army Medical Research and Materiel Command
7/1/20 → 6/30/23
Project: Research project
Targeting Posttranslational Modifications in Breast Carcinogenesis
Cristofanilli, M. & Wan, Y.
National Cancer Institute
4/15/20 → 3/31/25
Project: Research project
Molecular mechanisms underlying circulating tumor cell aggregation
Cristofanilli, M. & Liu, H.
National Cancer Institute
4/11/20 → 3/31/25
Project: Research project
Prot #DCC-2036-01-003: An Open-Label, Multicenter, Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination with Paclitaxel to Assess Safety, Tolerability, and Pharmacokinetics in Patients with Advanced or Metastatic Solid Tumors
Cristofanilli, M.
Deciphera Pharmaceuticals, LLC
9/6/19 → 9/6/22
Project: Research project
Fellowship in support of Paola D'Amico
Cristofanilli, M.
American-Italian Cancer Foundation
8/1/19 → 11/20/21
Project: Research project
Prot #G1T48-01: A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Ascending Doses of G1T48 in Women with Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Cristofanilli, M.
DrugDev Inc., G1 Therapeutics, Inc.
7/16/19 → 7/16/22
Project: Research project
Prot #CD07_TNBC: A Phase Ib/II Study of Leronlimab (PRO 140) Combined with Carboplatin in Patients with CCR5+ Metastatic Triple-Negative Breast Cancer (mTNBC)
Cristofanilli, M.
Amarex Clinical Research, CytoDyn Inc.
7/8/19 → 7/8/22
Project: Research project
Immune control of triple negative breast cancer by WEE1 inhibition
Cristofanilli, M. & Zhang, B.
U.S. Army Medical Research and Materiel Command
3/15/19 → 3/14/22
Project: Research project
Prot #17-101/NU DF17B11: Palbociclib after CDK and Endocrine Therapy (PACE): A Randomized Phase II study of Fulvestrant, Palbociclib, and Avelumab for Endocrine Pre-treated ER+/HER2- Metastatic Breast Cancer
Cristofanilli, M.
Dana-Farber/Partners CancerCare, Inc., Pfizer Inc.
10/4/18 → 10/4/21
Project: Research project
The Robert H. Lurie Comprehensive Cancer Center
Agulnik, M., Awatramani, R., Cella, D., Chakravarti, D., Chandel, N., Crispino, J. D., Cristofanilli, M., Eklund, E. A., Frankfurt, O., Horbinski, C. M., Horvath, C. M., Hussain, M., James, C. D., Kelleher, N. L., Khan, S. A., LaBonne, C., Larson, A. C., Matei, D. E., Mrksich, M., Munshi, H. G., Murphy, A. B., Penedo, F. J., Perlman, H. R., Peter, M. E., Rademaker, A. W., Rappoport, J. Z., Scheidt, K. A., Simon, M. A., Sosman, J. A., Spring, B., Wei, J., Weiss, E. L., Woloschak, G. E., Obeng, R., Hitsman, B. L., Butt, Z., Arvanitis, C., Wignall, S., Shilatifard, A., Kocherginsky, M., Rini, C., Bonini, M., Kumthekar, P. U., Mondragon, A., Benson III, A. B., Gordon, L. I., Green, K. J., Rosenzweig, A. C., Meade, T. J., Platanias, L. C., Carthew, R. W., Backman, V. & Hahn, E. A.
National Cancer Institute
8/10/18 → 7/31/23
Project: Research project
Infrastructure: Illinois Precision Medicine Consortium (IPMC)
Ackermann, R. T., Chisholm, R. L., Cristofanilli, M., Greenland, P., Kho, A. N., Ho, J., Simon, M. A., Smith, M. E. & Wehbe, F.
Office of the Director, National Institutes of Health
6/1/18 → 5/31/23
Project: Research project
Prot #ANG-002: HOMING Study: Harvest of Circulating Tumor Cells (CTCs) from Patients with Metastatic Breast Cancer (MBC) Using the ParsortixTM PC1 System
Cristofanilli, M.
ANGLE Europe Limited
5/11/18 → 5/11/21
Project: Research project
Characterization of clustered CTCs to eliminate breast cancer metastasis
Cristofanilli, M., Liu, H. & Liu, X.
U.S. Army Medical Research and Materiel Command
1/1/18 → 5/31/21
Project: Research project
A population-based approach to single CTC analysis in metastatic breast cancer
Cristofanilli, M. & Mu, Z.
Thomas Jefferson University, National Cancer Institute
8/15/17 → 7/31/22
Project: Research project
Prot #NU 16B14: I-CURE-1: A Phase II, single arm study of Pembrolizumab combined with carboplatin in patients with circulating tumor cells (CTCs) positive metastatic breast cancer (MBC)
Cristofanilli, M.
Merck Sharp & Dohme Corporation
7/25/17 → 7/25/23
Project: Research project
Prot #WI208835: NU 15B08: A Phase II Single Arm Study of Palbociclib in Patients with Metastatic HER2-positive and Triple Negative Breast Cancer with Brain Metastasis
Cristofanilli, M. & Santa-Maria, C. A.
Pfizer Inc.
4/25/16 → 4/30/21
Project: Research project